0001209191-23-056083.txt : 20231120
0001209191-23-056083.hdr.sgml : 20231120
20231120164138
ACCESSION NUMBER: 0001209191-23-056083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Funtleyder Leslie D.
CENTRAL INDEX KEY: 0001775394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 231423302
MAIL ADDRESS:
STREET 1: C/O APPLIED THERAPEUTICS, INC.
STREET 2: 340 MADISON AVENUE, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-220-9319
MAIL ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-20
0
0001697532
Applied Therapeutics Inc.
APLT
0001775394
Funtleyder Leslie D.
C/O APPLIED THERAPEUTICS, INC.
545 FIFTH AVENUE, SUITE 1400
NEW YORK
NY
10017
1
1
0
0
Chief Financial Officer
0
Common Stock
2023-11-20
4
A
0
300000
0.00
A
337148
D
Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan in connection with the Reporting Person's appointment as Chief Financial Officer. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. The compensatory Restricted Stock Units shall vest in equal monthly installments over the two-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such vesting date.
/s/ Shoshana Shendelman, as attorney-in-fact
2023-11-20